top of page
Search Results
All (10)
Posts (8)
Other Pages (2)
Results found for "Amgen"
Posts (8)
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ : AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered and cancer, today announced that the companies have entered into a definitive agreement under which Amgen
- 📰 GPCR Weekly News, January 1 to 7, 2024
Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR News Let’s dive into the Classified GPCR News from November 18th to 24th, 2024 Industry News Amgen
Other Pages (2)
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
Rottapel is a Senior Scientist at the Princess Margaret Cancer Centre where he holds the Amgen Chair
- Ep 53 with Dr. Timo De Groof
During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and
bottom of page